DiaKine Therapeutics' Acquisition

DiaKine Therapeutics was acquired by Islet Sciences on February 13, 2012.

DiaKine Therapeutics, Inc. is a development-stage company commercializing immune modulators such as Lisofylline (LSF) and related oral compounds into therapies for diabetes and related complications. …

Articles about DiaKine Therapeutics' Acquisition: